Mount Sinai Joins Test Validation Trial of bioAffinity’s CyPath® Lung
18 sept. 2018 14h00 HE
|
bioAffinity Technologies, Inc.
SAN ANTONIO, Sept. 18, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held biotech company, today announced that the Icahn School of Medicine at Mount Sinai (ISMMS) in New York, NY,...
bioAffinity Technologies to Present at Biotech Showcase™ Annual Conference
05 janv. 2018 09h00 HE
|
bioAffinity Technologies, Inc.
SAN ANTONIO, Texas, Jan. 05, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held cancer diagnostics company, today announced that it will present its proprietary technology to detect...
City of San Antonio Invests in bioAffinity Technologies
09 mars 2017 19h02 HE
|
bioAffinity Technologies, Inc.
SAN ANTONIO, March 09, 2017 (GLOBE NEWSWIRE) -- The San Antonio City Council today authorized the San Antonio Economic Development Corporation (SAEDC) to invest in locally based bioAffinity...
bioAffinity Technologies Announces Award of Hong Kong Patent
15 nov. 2016 09h00 HE
|
bioAffinity Technologies, Inc.
SAN ANTONIO, Nov. 15, 2016 (GLOBE NEWSWIRE) -- bioAffinity Technologies announced that the government of the Hong Kong Special Administrative Region has awarded a Certificate of Grant of Standard...
bioAffinity Technologies and UT Health Science Center Collaborate to Optimize Cancer Diagnostics and Therapeutics
13 juil. 2016 08h00 HE
|
bioAffinity Technologies, Inc.
SAN ANTONIO, July 13, 2016 (GLOBE NEWSWIRE) -- bioAffinity Technologies today announced the renewal of its collaborative agreement with The University of Texas Health Science Center at San Antonio...
bioAffinity Technologies Forms Subsidiary to Focus on Targeted Cancer Drug Delivery
23 juin 2016 08h00 HE
|
bioAffinity Technologies, Inc.
SAN ANTONIO, Texas, June 23, 2016 (GLOBE NEWSWIRE) -- bioAffinity Technologies today announced the formation of OncoSelect Therapeutics, LLC, a subsidiary company that will leverage bioAffinity’s...
bioAffinity Technologies Presents CyPath® Technology at International Lung Cancer Conference
12 avr. 2016 09h00 HE
|
bioAffinity Technologies, Inc.
SAN ANTONIO, April 12, 2016 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held cancer diagnostics company, will present its proprietary technology for the detection of early-stage lung...